The Surfers are joined by Jeff McIntyre of the Global Liver Institute (GLI) for a thought-provoking impromptu session on what’s happening thus far for the Fatty Liver field in 2023.
In this conversation, Jeff continues on collaborative work by GLI to more formally “medicalize” obesity as a term considerate of genetic backgrounds and metabolic dynaminisms. He relates this grappling around nomenclature to that experienced in the Fatty Liver forum. Comments shift toward the subject of nutrition and an ominous landscape of public health policy. Jeff calls for hepatology associations to join efforts in assessing package nutrition labeling, advocating for reductions of high fructose corn syrup and other measures of rectifying harmful food marketing to children. He notes there to be a conversation around rule-making happening at the FDA right now on what defines a “healthy” food. Jeff asserts that, “frankly, chronic disease is really underrepresented in that conversation.” Worse yet, representatives of those companies pushing the agenda of junk food are ascertained to be present and lobbying for their products one way or another. At this point, the other panelists voice impressions to these concerns.
If you enjoy the episode, have questions or interest around its contents and Fatty Liver disease, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at questions@SurfingNASH.com.
Stay Safe and Surf On!